Cells and biomaterials in cartilage tissue engineering

Regenerative Medicine

Volumn 4, Issue 1, 2009, Pages 81-98

  Stoddart, Martin ^a   Grad, Sibylle ^a   Eglin, David ^a   Alini, Mauro ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

Author keywords

Cartilage; Chondrocytes; Hydrogels; Scaffolds; Stem cells; Tisue engineering

Indexed keywords

BIOMATERIAL; BIOPOLYMER; CHONDROITIN SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HYALURONIC ACID; MACROGOL; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR BB; POLYCAPROLACTONE; POLYETHERURETHAN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE; ARTICULAR CARTILAGE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CARTILAGE; CARTILAGE CELL; CELL ADHESION; CELL COMPOSITION; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL REGENERATION; CHONDROGENESIS; CLINICAL TRIAL; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MESENCHYME CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TISSUE ENGINEERING; TISSUE STRUCTURE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CYTOLOGY; METABOLISM; METHODOLOGY; REGENERATION; STEM CELL; TRANSPLANTATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARTILAGE; CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; REGENERATION; STEM CELLS; TISSUE ENGINEERING;

EID: 58949086236     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.4.1.81     Document Type: Review

References (201)

1. Hunziker EB, Quinn TM, Hauselmann HJ: Quantitative structural organization of normal adult human articular cartilage. Osteoarthr. Cartil. 10, 564-572 (2002).
2. Eyre D: Collagen of articular cartilage. Arthritis Res. 4(1), 30-35 (2002).
3. Soder S, Hambach L, Lissner R, Kirchner T, Aigner T: Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. Osteoarthr. Cartil. 10(6), 464-470 (2002).
4. Darling EM, Hu JC, Athanasiou KA: Zonal and topographical differences in articular cartilage gene expression. J. Orthop. Res. 22(6), 1182-1187 (2004).
5. Darling EM, Athanasiou KA: Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng. 11(3-4), 395-403 (2005).
6. Klein TJ, Schumacher BL, Schmidt TA et al.: Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthr. Cartil. 11(8), 595-602 (2003).
7. Aydelotte MB, Kuettner KE: Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect. Tissue Res. 18(3), 205-222 (1988).
8. Aydelotte MB, Greenhill RR, Kuettner KE: Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect. Tissue Res. 18(3), 223-234 (1988).
9. DiMicco MA, Patwari P, Siparsky PN et al.: Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. Arthritis Rheum. 50(3), 840-848 (2004).
10. Davis MA, Ettinger WH, Neuhaus JM, Cho SA, Hauck WW: The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Am. J. Epidemiol. 130(2), 278-288 (1989).
11. Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ: Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann. Intern. Med. 133(5), 321-328 (2000).
12. Mankin HJ: The response of articular cartilage to mechanical injury. J. Bone Joint Surg. Am. 64(3), 460-466 (1982).
13. Tepper S, Hochberg MC: Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I). Am. J. Epidemiol. 137(10), 1081-1088 (1993).
14. Langer R, Vacanti JP: Tissue engineering. Science 260(5110), 920-926 (1993).
15. Adkisson HD, Gillis MP, Davis EC, Maloney W, Hruska KA: In vitro generation of scaffold independent neocartilage. Clin. Orthop. 391, 280-294 (2001).
16. Anderer U, Libera J: In vitro engineering of human autogenous cartilage. J. Bone Miner. Res. 17(8), 1420-1429 (2002).
17. Chia SH, Schumacher BL, Klein TJ et al.: Tissue-engineered human nasal septal cartilage using the alginate-recovered-chondrocyte method. Laryngoscope 114, 38-45 (2004).
18. Jubel A, Andermahr J, Schiffer G et al.: Transplantation of de novo scaffold-free cartilage implants into sheep knee chondral defects. Am. J. Sports Med. 36(8), 1555-1564 (2008).
19. Masuda K, Sah RL, Hejna MJ, Thonar EJ: A novel two-step method for the formation of tissue-engineered cartilage by mature bovine chondrocytes: the alginate-recovered-chondrocyte (ARC) method. J. Ortho. Res. 21, 139-148 (2003).
20. Stoddart MJ, Ettinger L, Hauselmann HJ: Generation of a scaffold free cartilage-like implant from a small amount of starting material. J. Cell Mol. Med. 10(2), 480-492 (2006).
21. Homicz MR, Chia SH, Schumacher BL et al.: Human septal chondrocyte redifferentiation in alginate, polyglycolic acid scaffold, and monolayer culture. Laryngoscope 113, 25-32 (2003).
22. Kuo YC, Ku IN: Effects of gel concentration, human fibronectin, and cation supplement on the tissue-engineered cartilage. Biotechnol. Prog. 23(1), 238-245 (2007).
23. Lee CR, Grad S, Gorna K, Gogolewski S, Goessl A, Alini M: Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng. 11(9-10), 1562-1573 (2005).
24. Mouw JK, Case ND, Guldberg RE, Plaas AH, Levenston ME: Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering. Osteoarthr. Cartil. 13(9), 828-836 (2005).
25. Nishimoto S, Takagi M, Wakitani S, Nihira T, Yoshida T: Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes. J. Biosci. Bioeng. 100(1), 123-126 (2005).
26. Yamaoka H, Asato H, Ogasawara T et al.: Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials. J. Biomed. Mater. Res. 78(1), 1-11 (2006).
27. Grad S, Lee CR, Gorna K, Gogolewski S, Wimmer MA, Alini M: Surface motion upregulates superficial zone protein and hyaluronan production in chondrocyte-seeded three-dimensional scaffolds. Tissue Eng. 11(1-2), 249-256 (2005).
28. Grad S, Lee CR, Wimmer MA, Alini M: Chondrocyte gene expression under applied surface motion. Biorheology 43(3-4), 259-269 (2006).
29. Hansen U, Schunke M, Domm C et al.: Combination of reduced oxygen tension and intermittent hydrostatic pressure: a useful tool in articular cartilage tissue engineering. J. Biomech. 34(7), 941-949 (2001).
30. Hunter CJ, Mouw JK, Levenston ME: Dynamic compression of chondrocyte-seeded fibrin gels: effects on matrix accumulation and mechanical stiffness. Osteoarthr. Cartil. 12(2), 117-130 (2004).
31. Krishnan R, Mariner EN, Ateshian GA: Effect of dynamic loading on the frictional response of bovine articular cartilage. J. Biomech. 38(8), 1665-1673 (2005).
32. Lee DA, Noguchi T, Knight MM, O'Donnell L, Bentley G, Bader DL: Response of chondrocyte subpopulations cultured within unloaded and loaded agarose. J. Orthop. Res. 16(6), 726-733 (1998).
33. Mauck RL, Byers BA, Yuan X, Tuan RS: Regulation of cartilaginous ECM gene transcription by chondrocytes and MSCs in 3D culture in response to dynamic loading. Biomech. Model. Mechanobiol. 6(1-2), 113-125 (2007).
34. Stoddart MJ, Ettinger L, Hauselmann HJ: Enhanced matrix synthesis in de novo, scaffold free cartilage-like tissue subjected to compression and shear. Biotechnol. Bioeng. 95(6), 1043-1051 (2006).
35. Jakob M, Demarteau O, Schafer D et al.: Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell. Biochem. 81(2), 368-377 (2001).
36. Liu G, Kawaguchi H, Ogasawara T et al.: Optimal combination of soluble factors for tissue engineering of permanent cartilage from cultured human chondrocytes. J. Biol. Chem. 282(28), 20407-20415 (2007).
37. Martin I, Vunjak-Novakovic G, Yang J, Langer R, Freed LE: Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp. Cell Res. 253, 681-688 (1999).
38. Porter RM, Akers RM, Howard RD, Forsten-Williams K: Alginate encapsulation impacts the insulin-like growth factor-I system of monolayer-expanded equine articular chondrocytes and cell response to interleukin-1β. Tissue Eng. 13(6), 1333-1345 (2007).
39. van den Berg W, van der Kraan P, Scharstuhl A, van Beuningen H: Growth factors and cartilage repair. Clin. Orthop. Relat. Res. 391S, 244-250 (2001).
40. van Osch GJ, van den Berg WB, Hunziker EB, Hauselmann HJ: Differential effects of IGF-1 and TGF β-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthr. Cartil. 6, 187-195 (1998).
41. Yoon DM, Fisher JP: Effects of exogenous IGF-1 delivery on the early expression of IGF-1 signaling molecules by alginate embedded chondrocytes. Tissue Eng. Part A 14(7), 1263-1273 (2008).
42. Feng G, Wan Y, Balian G, Laurencin CT, Li X: Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells. Growth Factors 26(3), 132-142 (2008).
43. Gouze JN, Stoddart MJ, Gouze E et al.: In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol. Med. 100, 147-164 (2004).
44. Palmer GD, Steinert A, Pascher A et al.: Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol. Ther. 12(2), 219-228 (2005).
45. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331(14), 889-895 (1994).
46. Brittberg M, Tallheden T, Sjogren-Jansson B, Lindahl A, Peterson L: Autologous chondrocytes used for articular cartilage repair: an update. Clin. Orthop. Relat. Res. 391, S337-S348 (2001).
47. Brittberg M, Peterson L, Sjogren-Jansson E, Tallheden T, Lindahl A: Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J. Bone Joint Surg. Am. 85A (Suppl. 3), 109-115 (2003).
48. Jones DG, Peterson L: Autologous chondrocyte implantation. J. Bone Joint Surg. Am. 88(11), 2502-2520 (2006).
49. Bartlett W, Gooding CR, Carrington RW, Skinner JA, Briggs TW, Bentley G: Autologous chondrocyte implantation at the knee using a bilayer collagen membrane with bone graft. A preliminary report. J. Bone Joint Surg. Br. 87(3), 330-332 (2005).
50. Bartlett W, Skinner JA, Gooding CR et al.: Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J. Bone Joint Surg. Br. 87(5), 640-645 (2005).
51. Ronga M, Grassi FA, Bulgheroni P: Arthroscopic autologous chondrocyte implantation for the treatment of a chondral defect in the tibial plateau of the knee. Arthroscopy 20(1), 79-84 (2004).
52. Hollander AP, Dickinson SC, Sims TJ et al.: Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng. 12(7), 1787-1798 (2006).
53. Behrens P, Bitter T, Kurz B, Russlies M: Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)-5 year follow-up. Knee 13(3), 194-202 (2006).
54. Marcacci M, Berruto M, Brocchetta D et al.: Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin. Orthop. Relat. Res. (435), 96-105 (2005).
55. Bentley G, Biant LC, Carrington RW et al.: A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J. Bone Joint Surg. Br. 85(2), 223-230 (2003).
56. Dozin B, Malpeli M, Cancedda R et al.: Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin. J. Sport Med. 15(4), 220-226 (2005).
57. Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R: Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J. Bone Joint Surg. Am. 85-A(2), 185-192 (2003).
58. Knutsen G, Engebretsen L, Ludvigsen TC et al.: Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am. 86-A(3), 455-464 (2004).
59. Benya PD, Shaffer JD: Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215-224 (1982).
60. Lin Z, Fitzgerald JB, Xu J et al.: Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J. Orthop. Res. 26(9), 1230-1237 (2008).
61. Chubinskaya S, Hakimiyan AA, Rappoport L, Yanke A, Rueger DC, Cole BJ: Response of human chondrocytes prepared for autologous implantation to growth factors. J. Knee Surg. 21(3), 192-199 (2008).
62. Barbero A, Ploegert S, Heberer M, Martin I: Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arhritis Rheum. 48(5), 1315-1325 (2003).
63. Binette F, McQuaid DP, Haudenschild DR, Yaeger PC, McPherson JM, Tubo R: Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J. Orthop. Res. 16(2), 207-216 (1998).
64. Bonaventure J, Kadhom N, Cohen-Solal L et al.: Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp. Cell Res. 212(1), 97-104 (1994).
65. Schulze-Tanzil G, de Souza P, Villegas CH et al.: Redifferentiation of dedifferentiated human chondrocytes in high-density cultures. Cell Tissue Res. 308(3), 371-379 (2002).
66. Dell'Accio F, De Bari C, Luyten FP: Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum. 44(7), 1608-1619 (2001).
67. Dell'Accio F, Vanlauwe J, Bellemans J, Neys J, De Bari C, Luyten FP: Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J. Orthop. Res. 21(1), 123-131 (2003).
68. Isogai N, Kusuhara H, Ikada Y et al.: Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Tissue Eng. 12(4), 691-703 (2006).
69. Johnson TS, Xu JW, Zaporojan VV et al.: Integrative repair of cartilage with articular and nonarticular chondrocytes. Tissue Eng. 10(9-10), 1308-1315 (2004).
70. Tay AG, Farhadi J, Suetterlin R, Pierer G, Heberer M, Martin I: Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng. 10(5-6), 762-770 (2004).
71. Chung C, Erickson IE, Mauck RL, Burdick JA: Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Tissue Eng. Part A 14(7), 1121-1131 (2008).
72. Kafienah W, Jakob M, Demarteau O et al.: Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng. 8(5), 817-826 (2002).
73. Vinatier C, Gauthier O, Masson M et al.: Nasal chondrocytes and fibrin sealant for cartilage tissue engineering. J. Biomed. Mater. Res. A (2008) (Epub ahead of print).
74. Vinatier C, Gauthier O, Fatimi A et al.: An injectable cellulose-based hydrogel for the transfer of autologous nasal chondrocytes in articular cartilage defects. Biotechnol. Bioeng. (2008) (Epub ahead of print).
75. Candrian C, Vonwil D, Barbero A et al.: Engineered cartilage generated by nasal chondrocytes is responsive to physical forces resembling joint loading. Arthritis Rheum. 58(1), 197-208 (2008).
76. Richmon JD, Sage AB, Shelton E, Schumacher BL, Sah RL, Watson D: Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer. Laryngoscope 115(9), 1553-1560 (2005).
77. Kim TK, Sharma B, Williams CG et al.: Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthr. Cartil. 11, 653-664 (2003).
78. Sharma B, Williams CG, Kim TK et al.: Designing zonal organization into tissue-engineered cartilage. Tissue Eng. 13(2), 405-414 (2007).
79. Waldman SD, Grynpas MD, Pilliar RM, Kandel RA: The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage. J. Orthop. Res. 21(1), 132-138 (2003).
80. Woodfield TB, van Blitterswijk CA, De Wijn J, Sims TJ, Hollander AP, Riesle J: Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Tissue Eng. 11(9-10), 1297-1311 (2005).
81. Li Z, Yao S, Alini M, Grad S: Different response of articular chondrocyte subpopulations to surface motion. Osteoarthr. Cartil. 15(9), 1034-1041 (2007).
82. Nugent-Derfus GE, Takara T, O'Neill JK et al.: Continuous passive motion applied to whole joints stimulates chondrocyte biosynthesis of PRG4. Osteoarthr. Cartil. 15(5), 566-574 (2007).
83. Stenhamre H, Slynarski K, Petren C, Tallheden T, Lindahl A: Topographic variation in redifferentiation capacity of chondrocytes in the adult human knee joint. Osteoarthr. Cartil. 16(11), 1356-1362 (2008).
84. Rogers BA, Murphy CL, Cannon SR, Briggs TW: Topographical variation in glycosaminoglycan content in human articular cartilage. J. Bone Joint Surg. Br. 88(12), 1670-1674 (2006).
85. Little CB, Ghosh P: Variation in proteoglycan metabolism by articular chondrocytes in different joint regions is determined by post-natal mechanical loading. Osteoarthr. Cartil. 5(1), 49-62 (1997).
86. Cassiede P, Dennis JE, Ma F, Caplan AI: Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β 1 or PDGF-BB as assayed in vivo and in vitro. J. Bone Miner. Res. 11(9), 1264-1273 (1996).
87. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU: In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238(1), 265-272 (1998).
88. Pittenger MF, Mackay AM, Beck SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147 (1999).
89. Wan C, He Q, McCaigue M, Marsh D, Li G: Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs). J. Orthop. Res. 24(1), 21-28 (2006).
90. + cells. Stem Cells 24(7), 1728-1737 (2006).
91. Jones EA, English A, Kinsey SE et al.: Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin. Cytom. 70(6), 391-399 (2006).
92. + marrow cell population is multipotential. Cells Tissues Organs 170(2-3), 73-82 (2002).
93. Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino AC: A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. 16(6), 953-963 (2007).
94. Bianchi G, Banfi A, Mastrogiacomo M et al.: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp. Cell Res. 287(1), 98-105 (2003).
95. Tsutsumi S, Shimazu A, Miyazaki K et al.: Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 288(2), 413-419 (2001).
96. Mastrogiacomo M, Cancedda R, Quarto R: Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthr. Cartil. 9(Suppl. A), S36-S40 (2001).
97. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57(1), 11-20 (2003).
98. Di Nicola M, Carlo-Stella C, Magni M et al.: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10), 3838-3843 (2002).
99. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D: Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11(3), 343-353 (2008).
100. Kuroda R, Ishida K, Matsumoto T et al.: Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr. Cartil. 15(2), 226-231 (2007).
101. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S: Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13(5), 595-600 (2004).
102. Barry F, Boynton RE, Liu B, Murphy JM: Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp. Cell Res. 268(2), 189-200 (2001).
103. Ma HL, Hung SC, Lin SY, Chen YL, Lo WH: Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J. Biomed. Mater. Res. A 64(2), 273-281 (2003).
104. Winter A, Breit S, Parsch D et al.: Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 48(2), 418-429 (2003).
105. Dowthwaite GP, Bishop JC, Redman SN et al.: The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 117(Pt 6), 889-897 (2004).
106. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T: Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol. Bioeng. 93(6), 1152-1163 (2006).
107. Huang CY, Reuben PM, D'Ippolito G, Schiller PC, Cheung HS: Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 278(1), 428-436 (2004).
108. Li W, Tuli R, Okafor C et al.: A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26, 599-609 (2005).
109. Li Z, Kupcsik L, Yao S, Alini M, Stoddart MJ: Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng. (2008) (In Press).
110. Angele P, Schumann D, Angele M et al.: Cyclic, mechanical compression enhances chondrogenesis of mesenchymal progenitor cells in tissue engineering scaffolds. Biorheology 41(3-4), 335-346 (2004).
111. Huang CY, Hagar KL, Frost LE, Sun Y, Cheung HS: Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 22(3), 313-323 (2004).
112. Schumann D, Kujat R, Nerlich M, Angele P: Mechanobiological conditioning of stem cells for cartilage tissue engineering. Biomed. Mater. Eng. 16(Suppl. 4), S37-S52 (2006).
113. Kafienah W, Mistry S, Perry MJ, Politopoulou G, Hollander AP: Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells 25(10), 2460-2468 (2007).
114. Weston AD, Chandraratna RA, Torchia J, Underhill TM: Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. J. Cell. Biol. 158(1), 39-51 (2002).
115. Cucchiarini M, Madry H: Gene therapy for cartilage defects. J. Gene Med. 7(12), 1495-1509 (2005).
116. Pascher A, Palmer G, Steinert A et al.: Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther. 11, 133-141 (2004).
117. Bujan J, Pascual G, Corrales C, Gomez-Gil V, Garcia-Honduvilla N, Bellon JM: Muscle-derived stem cells used to treat skin defects prevent wound contraction and expedite reepithelialization. Wound Repair Regen. 14(2), 216-223 (2006).
118. Rochefort GY, Delorme B, Lopez A et al.: Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24(10), 2202-2208 (2006).
119. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM: Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30(8), 896-904 (2002).
120. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B: Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J. Orthop. Res. 23(6), 1383-1389 (2005).
121. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B: Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25(3), 750-760 (2007).
122. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV: Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16(3), 381-390 (1966).
123. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3(4), 393-403 (1970).
124. Bernardo ME, Emons JA, Karperien M et al.: Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect. Tissue Res. 48(3), 132-140 (2007).
125. Chen G, Sato T, Ushida T, Ochiai N, Tateishi T: Tissue engineering of cartilage using a hybrid scaffold of synthetic polymer and collagen. Tissue Eng. 10(3/4), 323-231 (2004).
126. Im GI, Shin YW, Lee KB: Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr. Cartil. 13(10), 845-853 (2005).
127. De Ugarte DA, Morizono K, Elbarbary A et al.: Comparison of multilineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174(3), 101-109 (2003).
128. Izadpanah R, Trygg C, Patel B et al.: Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell Biochem. 99(5), 1285-1297 (2006).
129. Rich JT, Rosova I, Nolta JA, Myckatyn TM, Sandell LJ, McAlinden A: Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 372(1), 230-235 (2008).
130. Zuk PA, Zhu M, Ashjian P et al.: Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279-4295 (2002).
131. Zuk PA, Zhu M, Mizuno H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211-228 (2001).
132. De Ugarte DA, Alfonso Z, Zuk PA et al.: Differential expression of stem cell mobilization-associated molecules on multilineage cells from adipose tissue and bone marrow. Immunol. Lett. 89(2-3), 267-270 (2003).
133. Hennig T, Lorenz H, Thiel A et al.: Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP-6. J. Cell. Physiol. 211(3), 682-691 (2007).
134. Nishimura K, Solchaga LA, Caplan AI, Yoo JU, Goldberg VM, Johnstone B: Chondroprogenitor cells of synovial tissue. Arthritis Rheum. 42(12), 2631-2637 (1999).
135. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44(8), 1928-1942 (2001).
136. Djouad F, Bony C, Haupl T et al.: Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res. Ther. 7(6), R1304-R1315 (2005).
137. Hutmacher DW: Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529-2543 (2000).
138. Pérez Olmedilla M, Garcia-Giralt N, Pradas MM et al.: Response of human chondrocytes to a nonuniform distribution of hydrophilic domains on poly (ethyl acrylate-co-hydroxyethyl methacrylate) copolymers. Biomaterials 27(7), 1003-1012 (2006).
139. Schlegel W, Nurnberger S, Hombauer M, Albrecht C, Vecsei V, Marlovits S: Scaffold-dependent differentiation of human articular chondrocytes. Int. J. Mol. Med. 22(5), 691-699 (2008).
140. Philp D, Chen SS, Fitzgerald W, Orenstein J, Margolis L, Kleinman HK: Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells 23(2), 288-296 (2005).
141. Curran JM, Chen R, Hunt JA: The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials 27, 4783-4793 (2006).
142. Dalby MJ, Gadegaard NJ, Tare R et al.: The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat. Mater. 6(12), 997-1003 (2008).
143. Häuselmann H, Adelotte MB, Schumacher BL, Kuettner KE, Gitelis SH, Thonar EJ: Sythesis and turnover of proteoglycans by human and bovine adult articular chondroctes cultured in alginate beads. Matrix 12, 116-129 (1992).
144. Vinatier C, Guicheux J, Daculsi G, Layrolle P, Weiss P: Cartilage and bone tissue engineering using hydrogel. Biomed. Mater. Eng. 16, S107-S113 (2006).
145. Karageorgiou V, Karino T: Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26, 5474-5491 (2005).
146. Grad S, Gogolewski S, Alini M, Wimmer MA: Effects of simple and complex motion patterns on gene expression of chondrocytes seeded in 3D scaffolds. Tissue Eng. 12(11), 3171-3179 (2006).
147. Bryant SJ, Anseth KS: Hydrogel properties nfiuence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J. Biomed. Mater. Res. 59(1), 63-72 (2002).
148. Buxton AN, Zhu J, Marchant R, West JL, Yoo JU, Johnstone B: Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells. Tissue Eng. 13(10), 1-12 (2007).
149. Ifkovits JL, Burdick JA: Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng. 13(10), 1-17 (2007).
150. Bryant SJ, Anseth KS: Controlling the spatial distribution of ECM components in degradable PEGhydrogels for tissue engineering cartilage. J. Biomed. Mater. Res. 64(1), 70-79 (2003).
151. Ferretti M, Marra KG, Kobayashi K, Defail AJ, Chu CR: Controlled in vivo degradation of genipin crosslinked polyethylene glycol hydrogels within osteochondral defects. Tissue Eng. 12(9), 2657-2665 (2006).
152. Meinel L, Hofmann S, Karageorgiou V et al.: Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol. Bioeng. 88(3), 379-391 (2004).
153. Haasper C, Zeichen J, Meister R, Krettek C, Jagodzinski M: Tissue engineering of osteochondral constructs in vitro using bioreactors. Injury 3951, S66-S76 (2008).
154. Facchini A, Lisignoli G, Cristino S et al.: Human chondrocytes and mesenchymal stem cells grown onto engineered scaffold. Biorheology 43(3-4), 471-480 (2006).
155. Grigolo B, Roseti L, Fiorini M et al.: Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials 22, 2417-2424 (2001).
156. Chang CH, Liu HC, Lin CC, Chou CH, Lin FH: Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Biomaterials 24, 4853-4858 (2003).
157. Abe M, Takahashi M, Nagano A: The effect of hyaluronic acid with different molecular weights on collagen crosslink synthesis in cultured chondrocytes embedded in collagen gels. J. Biomed. Mater. Res. A 75(2), 494-499 (2005).
158. Allemann F, Mizuno S, Eid K, Yates KE, Zaleske D, Glowacki J: Effects of hyaluronan on engineered articular cartilage extracellular matrix gene expression in 3D collagen scaffolds. J. Biomed. Mater. Res. 55(1), 13-19 (2001).
159. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M: Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J. Cell. Physiol. 179(2), 142-148 (1999).
160. Wu YN, Yang Z, Hui JH, Ouyang HW, Lee EH: Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells. Biomaterials 28(28), 4056-4067 (2007).
161. Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan KD: In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 26(34), 7082-7094 (2005).
162. Wang Y, Blasioli DJ, Kim HJ, Kim HS, Kaplan DL: Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 27(25), 4434-4442 (2006).
163. Meinel L, Hofmann S, Karageorgiou V et al.: The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26(2), 147-155 (2005).
164. Hoemann CD, Sun J, McKee MD et al.: Chitosan-glycerol phosphate/ blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects. Osteoarthr. Cartil. 15(1), 78-89 (2007).
165. Hoemann CD, Hurtig M, Rossomacha E et al.: Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. J. Bone Joint Surg. Am. 87(12), 2671-2686 (2005).
166. Lee JE, Kim KE, Kwon IC et al.: Effects of the controlled-released TGF-β1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25(18), 4163-4173 (2004).
167. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG: Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26(34), 7095-7103 (2005).
168. Uebersax L, Merkle HP, Meinel L: Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J. Control Release 127(1), 12-21 (2008).
169. Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E: Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds. Biomaterials 29(10), 1518-1525 (2008).
170. Bonzani IC, George JH, Stevens MM: Novel materials for bone and cartilage regeneration. Curr. Opin Chem. Biol. 10, 568-575 (2006).
171. Fairman R, Akerfeldt KS: Peptides as novel smart materials. Curr. Opin Struct. Biol. 15, 453-463 (2005).
172. Kisiday J, Jin M, Kurz B et al.: Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc. Natl Acad. Sci. USA 99(15), 9996-10001 (2002).
173. Kisiday JD, Jin M, DiMicco MA, Kurz B, Grodzinsky AJ: Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. J. Biomech. 37(5), 595-604 (2004).
174. Betre H, Setton LA, Meyer DE, Chilkoti A: Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules. 3(5), 910-916 (2002).
175. Trabbic-Carlson K, Setton LA, Chilkoti A: Swelling and mechanical behaviors of chemically cross-linked hydrogels of elastin-like polypeptides. Biomacromolecules. 4(3), 572-580 (2003).
176. Lim DW, Nettles DL, Setton LA, Chilkoti A: Rapid cross-linking of elastin-like polypeptides with (hydroxymethyl) phosphines in aqueous solution. Biomacromolecules 8(5), 1463-1470 (2007).
177. Lim DW, Nettles DL, Setton LA, Chilkoti A: In situ cross-linking of elastin-like polypeptide block copolymers for tissue repair. Biomacromolecules 9(1), 222-230 (2008).
178. McHale MK, Setton LA, Chilkoti A: Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng. 11(11-12), 1768-1779 (2005).
179. Betre H, Ong SR, Guilak F, Chilkoti A, Fermor B, Setton LA: Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials 27(1), 91-99 (2006).
180. Park Y, Lutolf MP, Hubbell JA, Hunziker EB, Wong M: Bovine primary chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng. 10(3-4), 515-522 (2004).
181. Sah RL, Trippel SB, Grodzinsky AJ: Differential effects of serum, insulin-like growth factor-I, and fibroblast growth factor-2 on the maintenance of cartilage physical properties during long-term culture. J. Orthop. Res. 14, 44-52 (1996).
182. Raimondi MT, Falcone L, Colombo M et al.: A comparative evaluation of chondrocyte/scaffold constructs for cartilage tissue engineering. J. App. Biomater. Biomech. 2, 55-64 (2004).
183. Zwingmann J, Mehlhorn AT, Südkamp N, Stark B, Dauner M, Schmal H: Chondrogenic differentiation of human articular chondrocytes differs in biodegradable PGA/PLA scaffolds. Tissue Eng. 13(9), 2335-2343 (2007).
184. Li W-J, Jiang YJ, Tuan RS: Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng. 12(7), 1775-1785 (2006).
185. Wendt D, Marsano A, Jakob M, Heberer M, Martin I: Oscillating perfusion of cell suspensions through 3D scaffolds enhances cell seeding efficiency and uniformity. Biotechnol. Bioeng. 84(2), 205-214 (2003).
186. Martin I, Obradovic B, Treppo S et al.: Modulation of the mechanical properties of tissue engineered cartilage. Biorheology 37(1-2), 141-147 (2000).
187. Vunjak-Novakovic G, Martin I, Obradovic B et al.: Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J. Orthop. Res. 17(1), 130-138 (1999).
188. Paige KT, Vacanti CA: Engineering new tissue: formation of neo-cartilage. Tissue Eng. 1(2), 97-107 (1995).
189. Moutos FT, Freed LE, Guilak F: A biomimetic 3D woven composites scaffold for functional tissue engineering of cartilage. Nat. Mater. 6, 162-167 (2007).
190. Eyrich D, Wiese H, Maier G et al.: In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng. 13(9), 1-12 (2007).
191. Cohen S, Meirisch C, Wilson H, Diduch D: The use of absorbable co-polymer pads with alginate and cells for articular cartilage repair in rabbits. Biomaterials 24, 2653-2660 (2003).
192. Hannouche D, Terai H, Fuchs JR et al.: Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells. Tissue Eng. 13(1), 87-99 (2007).
193. Wernike E, Li Z, Alini M, Grad S: Effect of reduced oxygen tension on long-term mechanical stimulation on chondrocyte-polymer constructs. Cell Tissue Res. 331(2), 473-483 (2008)
194. Stevens MM, Marini RP, Schaefer D, Aronson J, Langer R, Shastri VP: In vivo engineering of organs: the bone bioreactor. Proc. Natl Acad. Sci. USA 102(32), 11450-11455 (2005).
195. Lu Y, Dhanaraj S, Wang Z et al.: Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J. Orthop. Res. 24(6), 1261-1270 (2006).
196. Mercier NR, Costantino HR, Tracy MA, Bonassar LJ: Poly(lactide-co-glycolide) microspheres as a moldable scaffold for cartilage tissue engineering. Biomaterials 26(14), 1945-1952 (2005).
197. Tuli R, Nandi S, Li WJ et al.: Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng. 10(7-8), 1169-1179 (2004).
198. Ghodsizad A, Klein HM, Borowski A et al.: Intraoperative isolation and processing of BM-derived stem cells. Cytotherapy 6(5), 523-526 (2004).
199. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317 (2007).
200. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007).
201. Evans CH, Robbins PD, Ghivizzani SC et al.: Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc. Natl Acad. Sci. USA 102(24), 8698-8703 (2005).